Trials / Completed
CompletedNCT01137396
Modafinil, Sleep Architecture and Cocaine Relapse
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The medication modafinil has been shown to reduce cocaine use in some cocaine users. The investigators have shown that modafinil taken in the morning improves sleep in chronic cocaine users. The investigators hypothesize that the beneficial effects of modafinil in reducing cocaine use may be related to specific effects modafinil has on sleep. This study will measure sleep and cocaine use in cocaine dependent persons who are trying to stop using cocaine, and will test the connection between modafinil's effects on sleep and cocaine use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Modafinil | Modafinil 400mg PO QDaily following up-titration for \~8weeks |
| BEHAVIORAL | Cognitive Behavioral Therapy | Once weekly cognitive behavioral therapy for cocaine dependence |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2010-06-04
- Last updated
- 2016-04-27
- Results posted
- 2016-04-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01137396. Inclusion in this directory is not an endorsement.